Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors
US8796310B2 · kind B2 · utility
15Cited by
1References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2012 |
| Grant date | Aug 5, 2014 |
| Priority date | — |
| Expiry date | Apr 30, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides certain amino-pyridine-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and n are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.